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Path-seq identifies an essential mycolate
remodeling program for mycobacterial
host adaptation
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Abstract
The success of Mycobacterium tuberculosis (MTB) stems from its
ability to remain hidden from the immune system within macro-
phages. Here, we report a new technology (Path-seq) to sequence
miniscule amounts of MTB transcripts within up to million-fold
excess host RNA. Using Path-seq and regulatory network analyses,
we have discovered a novel transcriptional program for in vivo
mycobacterial cell wall remodeling when the pathogen infects
alveolar macrophages in mice. We have discovered that MadR
transcriptionally modulates two mycolic acid desaturases desA1/
desA2 to initially promote cell wall remodeling upon in vitro
macrophage infection and, subsequently, reduces mycolate biosyn-
thesis upon entering dormancy. We demonstrate that disrupting
MadR program is lethal to diverse mycobacteria making this evolu-
tionarily conserved regulator a prime antitubercular target for
both early and late stages of infection.
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Introduction
Mycobacterium tuberculosis (MTB) infection occurs by inhalation of
bacilli-containing aerosols. Alveolar macrophages, which line the
airway, are the first host cells to phagocytize the bacteria. This ini-
tial contact of MTB with alveolar macrophages begins a complex
battle between bacterial virulence and host immunity, orchestrated
in large part by intricate gene regulatory pathways (Galan & Wolf-
Watz, 2006; Medzhitov, 2007). As such, measuring gene expression
in vivo is central to our understanding of TB disease control and
progression (Flynn et al, 2011).
RNA-seq provides a sensitive method for global gene expres-
sion analysis. Specific for infection biology, dual RNA-seq meth-
ods have allowed simultaneous profiling of host and pathogen
RNA. However, the striking excess of eukaryotic over bacterial
RNA limits the coverage of pathogen transcripts in dual RNA-seq
studies (Avraham et al, 2015, 2016, Rienksma et al, 2015; Wester-
mann et al, 2012; Westermann et al, 2016), and methods to par-
tially enrich for bacterial transcripts have had limited success
(Humphrys et al, 2013; Mavromatis et al, 2015). It is clear that
more sensitive approaches are needed to profile the tran-
scriptional state of the pathogen during infection, especially
in vivo.
To improve the coverage of pathogen transcripts, we made
use of biotinylated oligonucleotide baits that are complementary
to the pathogen transcriptome. The baits are hybridized to
mixed host–pathogen RNA and used to enrich pathogen tran-
scripts for sequencing. Approaches using biotinylated genome
fragments have previously been used to enrich specific tran-
scripts of intracellular pathogens (Graham & Clark-Curtiss, 1999;
Morrow et al, 1999) or perform genome-wide transcriptome pro-
filing of fungal RNA from infected host cells (Amorim-Vaz et al,
2015). Here, we applied our pathogen-sequencing (Path-seq)
method to explore transcriptional changes in MTB (one-fourth
the size of fungus, Candida albicans) following infection in
mice. Path-seq data along with network modeling have led to
discovery that MTB transcriptionally regulates mycolic acids dur-
ing infection of host cells, influencing virulence and persistence
of the pathogen.
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Results
Development of Path-seq
To enrich the bacterial pathogen transcripts, we used Agilent eArray
(Ong et al, 2011) to create a custom bait library that covers all MTB
transcripts at even intervals. Our MTB library contains 35,624
probes, each with biotinylated oligonucleotides of 120 base lengths.
The bait library composition is modular and can be designed to
cover specific transcripts of interest. Similarly, transcripts such as
rRNA can be excluded or gene sequences altered for polymorphisms
found in clinical strains (Fleischmann et al, 2002). For this study,
we chose all transcripts of MTB H37Rv for complete coverage and
comparison with standard RNA-seq results.
To assess enrichment of pathogen transcripts, we first used RNA
isolated from murine bone marrow-derived macrophages (BMDMs)
spiked with 0.1% MTB RNA. A typical mammalian cell contains on
the order of 20 picograms of RNA, which is roughly two orders of
magnitude more than a single bacterial cell (Alberts et al, 1994).
Accounting for BMDMs that might not be infected and based on
intracellular sequencing studies from literature (Avraham et al,
2016; Westermann et al, 2016), we estimated 0.1% pathogen RNA
would be representative of a typical in vitro infection. We performed
double rRNA depletion using Illumina Ribo-Zero Gold Epidemiology
Kit and used the SureSelect protocol to generate strand-specific
libraries for sequencing. Half of the library was then indexed for
sequencing as the “RNA-seq” sample, and the other was hybridized
to the probes, amplified, and indexed as the “Path-seq” sample
(Fig 1A). We performed three replicate experiments of the mock
infection using the same MTB RNA. With the probe hybridization,
the percentages of reads aligned to MTB were increased up to
840-fold. Both the normalized read counts (Fig 1B) and enrichment
efficiency (inset Fig 1B) were highly reproducible across three repli-
cate samples. Repeating the Path-seq method with spiked RNA sam-
ples, we increased the proportion of macrophage RNA and were
able to quantify MTB transcripts from one millionth of the host RNA
(1.75% of all reads aligned to MTB genomes).
To validate the enrichment protocol yielded quantitatively reli-
able read counts, we investigated the correlation between the
RPKMs obtained from the sequencing of RNA from in vitro grown
MTB, without enrichment (RNA-seq), and the RPKM values
obtained with the enrichment protocol (Path-seq) using the same
0.1% MTB RNA with host RNA (BMDMs). Even using different
library preparation kits (Illumina for RNA-seq and Agilent for Path-
seq), the correlation of RPKMs was 0.92–0.93 (Fig 1C), demonstrat-
ing the enrichment process was efficient and accurate for gene
expression analysis.
Analysis of MTB transcriptome during in vivo infection using
Path-seq method
Little is known about the transcriptional state of the pathogen dur-
ing infection of animal models (Talaat et al, 2004); technical chal-
lenges have limited these studies. Given the enrichment capabilities
of the Path-seq method, we evaluated the use of the approach to
study the transcriptome of MTB isolated from alveolar macrophages
(AMs) of infected mice. We used fluorescence-activated cell sorting
(FACS) and gating strategies to isolate AMs from bronchoalveolar
lavage (BAL) of mice at 24 h post-aerosol infection with MTB. We
isolated AMs from BAL, instead of whole lung tissue, to avoid the
harsh digestion step at 37°C that can alter the transcriptional state
of the cells. RNA extracted from AMs in BAL of 10 mice yielded
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Figure 1. Path-seq workflow and validation.
A Total RNA from mock infection or infected cells was depleted of rRNA, and cDNA libraries were prepared. Libraries were then either indexed and sequenced directly
for host transcripts or enriched using pathogen-specific oligonucleotides bound to beads. After hybridization, enriched libraries were indexed, sequenced, and reads
assigned to host or pathogen genomes in silico.
B Correlation between replicate mock infections. Path-seq reads were recovered from samples of macrophage RNA spiked with 0.1% MTB RNA. Scatter plot of log2
RPKM values is shown with Pearson correlation, P-value < 0.0001. Inset summarizes the mock infection replicates and their fraction of MTB reads (of all aligned
reads) from Path-seq and standard RNA-seq methods.
C Correlation between MTB RNA sequenced by RNA-seq (Illumina TruSeq Library Prep) and the same MTB RNA sample combined with macrophage RNA at 1:1,000 ratio
and processed using Path-seq method. Scatter plot of log2 RPKM values is shown with Pearson correlation, P-value < 0.0001.
Molecular Systems Biology Path-seq reveals mycolate control by MadR Eliza JR Peterson et al
2 of 19 Molecular Systems Biology 15: e8584 | 2019 ª 2019 The Authors
Published online: March 4, 2019 
~100 lg of total RNA. Therefore, we first evaluated the Path-seq
method using 0.3 lg of BMDM RNA spiked with 0.005% MTB RNA,
to simulate mixed host and pathogen RNA composition of a sample
from an in vivo infection. We performed Path-seq with two repli-
cates, and alignment analysis revealed the percentages of reads that
aligned to MTB were 38 and 27%, an approximate 10,000-fold
enrichment.
After evaluating the Path-seq methods’ feasibility for in vivo
MTB transcriptome analysis, we used flow cytometry to isolate
AMs (average of 4.3% of all cells and 83.1% of live, CD45+
cells) in BAL of 30 mice 24 h after infection with wild-type MTB
(Appendix Fig S1A). Infection, FACS sorting (Appendix Fig S1B),
and RNA extraction were repeated with three independent mouse
infections (three biological replicates), yielding an average of
~300 lg total RNA per replicate. The Path-seq enrichment was
performed and resulted in 17, 8, and 5% of the entire reads
aligning to MTB from each of the replicates. We compared the
MTB read counts between the in vivo samples with extracellular
samples, biological replicates of RNA extracted from MTB grown
in 7H9 media for 24 h (starting OD600 = 0.1). Both the in vivo
and extracellular samples were processed by Path-seq. While the
percentage of non-zero reads and total read counts are lower in
the in vivo samples, the mean count per gene and coefficient of
variation are the same between the two conditions
(Appendix Table S1). This gives us confidence that for genes with
detectable reads, we are measuring real expression levels. We
suspect genes with non-detectable reads are a result of the minis-
cule amount of MTB RNA compared to host RNA in the in vivo
samples, and not a reflection of real gene expression changes.
Therefore, excluding genes with zero counts in all in vivo repli-
cates resulted in 3,505 MTB genes (62% of genome) with
sequenced expression measurements from in vivo infection using
Path-seq. These results (raw data and normalized read counts for
ALL genes are available in GEO: GSE116394) present the most
comprehensive transcriptome profiling of MTB from in vivo infec-
tion and a major technical advancement for researchers studying
host–pathogen interactions.
To calculate differentially expressed genes between the in vivo
and extracellular samples, we excluded in vivo biological replicate
3, which had significantly lower total read counts compared to all
other samples (summarized in Appendix Table S1). The lower depo-
sition of replicate 3 suggests a lower amount of starting MTB could
be the reason for the low read count. Differential expression analy-
sis between in vivo intracellular MTB and extracellular MTB identi-
fied 431 significantly differentially expressed transcripts (log2 fold
change < 1.0 or > 1.0 and multiple hypothesis-corrected
P-value < 0.05, Dataset EV1).
Among the differentially expressed transcripts that code for
annotated proteins (376 genes), 121 were down-regulated and sig-
nificantly enriched (multiple hypothesis-corrected P-value = 0.005),
in the Mycobrowser category (Kapopoulou et al, 2011) of proline–
glutamic acid (PE)/proline–proline–glutamic acid (PPE) family of
proteins. The exact physiological role of the PE and PPE proteins in
MTB is yet to be fully understood, but they are thought to play
important roles in immune evasion (Tiwari et al, 2012). It is inter-
esting that PE and PPE genes were down-regulated in AMs and
might indicate that they are unnecessary within these host cells. In
addition, 255 genes were up-regulated in AMs at 24 h post-infection
and were significantly enriched (P < 0.05) in the Mycobrowser
functional categories: “insertion sequences and phages”, “informa-
tion pathways”, and “lipid metabolism”. Most interesting, many of
the genes whose protein products are associated with “lipid meta-
bolism” are involved in the biosynthesis of mycolic acid. These
up-regulated mycolic acid biosynthesis genes included umaA, pcaA,
desA1, desA2, fadD32, and fabD. In addition, genes of the operon
involved in phthiocerol dimycocerosate (PDIM) biosynthesis were
also up-regulated. The biosynthesis of new cell wall material is an
energetically expensive process and found to be repressed in MTB
upon entry into dormancy (Galagan et al, 2013; Jamet et al, 2015).
This suggests that MTB in AMs 24 h post-infection are not in a dor-
mant state. Instead, the transcriptional response indicates MTB is
actively remodeling the cell wall, perhaps with modifications that
specifically contribute to survival within AMs. Interestingly, the up-
regulated genes, umaA and pcaA, are required for cyclopropane ring
formation in mycolic acids of MTB. Furthermore, desA1 and desA2
(with log2 fold change of 4.0 and 4.7, respectively, within AMs)
encode fatty acid desaturases that introduce double bonds into fatty
acids (Singh et al, 2016). Desaturation is a necessary step prior to
cyclopropanation and other mycolic acid modifications. It is interest-
ing to speculate that conditions within AMs induce desaturation
events, enabling MTB to fine-tune subsequent cyclopropanation and
other modifications of mycolic acids that contribute to cell wall per-
meability and adaptation within these host cells. The significant up-
regulation of mycolic acid remodeling genes following in vivo infec-
tion was interesting and deserved further investigation of their tran-
scriptional control.
Genome-wide expression analysis during in vitro macrophage
infection using Path-seq
Several genome-wide expression studies of MTB challenged with
dormancy-inducing stresses, such as nutrient starvation (Jamet
et al, 2015) and hypoxia (Galagan et al, 2013; McGillivray et al,
2015), have shown that genes involved in mycolic acid biosynthesis
are generally down-regulated. In contrast, we observed up-regula-
tion of mycolate biosynthesis genes in MTB from AMs of infected
mice at 24 h. Therefore, we sought to study the expression of these
mycolic acid modification genes at multiple time points during infec-
tion using the Path-seq method and MTB-infected bone marrow-
derived macrophages (BMDMs). An in vitro infection system was
used due to the large number of mice required for additional time
points during in vivo infection. We isolated murine BMDMs and
infected them with MTB at a MOI of 10. Infected cells were collected
at 2, 8, and 24 h after infection along with extracellular MTB grown
in 7H9 media as control. Total RNA was extracted, depleted of
rRNA, and handled as described above (Fig 1A). All extracellular
MTB samples were processed by Path-seq as well. For the in vitro
infection samples (Appendix Fig S2), we split each sample into
RNA-seq and Path-seq fractions to evaluate the enrichment effi-
ciency and to simultaneously obtain both host and pathogen tran-
scriptomes from the same infection sample. While we did not
perform transcriptome analysis of the host cells in this study, the
raw data are available (GSE116357) along with uninfected BMDM
controls and represents the first duel monitoring of both MTB and
host transcriptomes from the same infection samples. The percent-
age of reads that aligned to MTB was consistent at a 100-fold
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increase in the enriched vs non-enriched samples across replicates
and time points (Table 1). With an average of 11 million (M)
mapped reads for both intracellular (average 13.4 M) and extracel-
lular (average 8.8 M) MTB, we obtained >100× coverage and 5,622
unique features (including ncRNA and UTRs). This is further valida-
tion of the Path-seq method to comprehensively study the authentic
intracellular state of a pathogen.
Using the normalized read counts from the intracellular and
extracellular MTB data, we identified two clusters by implement-
ing the R NbClust function (Charrad et al, 2014) on principal com-
ponent analysis output, a dimensionality reduction method. The
two identified clusters are shown in a two-dimensional t-distrib-
uted stochastic neighbor embedding plot (t-SNE, van der Maaten &
Hinton, 2008) plot. Extracellular samples clustered closely
together, distinct from the intracellular samples and according to
their time post-infection (Appendix Fig S3A). Biological replicates
fell into related groups and demonstrated strong correlation in
pairwise comparison of RPKMs (Appendix Fig S3B). Differential
expression of intracellular MTB was calculated relative to extracel-
lular, at each time point using DESeq2. Overall, there were 746,
945, and 412 significant differentially expressed (log2 fold change
< 1.0 or > 1.0 and multiple hypothesis-adjusted P-value < 0.01)
transcripts at the 2, 8, and 24 h post-infection time points, respec-
tively (Dataset EV2). The most up-regulated genes at all time
points included genes such as icl1, Rv1129c, prpD, prpC, and
fadD19. The induced expression of these genes is consistent with
known alterations in lipid degradation during infection, enhanced
activity of the methylcitrate cycle (Munoz-Elias et al, 2006), and
genetic evidence that MTB utilizes cholesterol from the host dur-
ing infection (Pandey & Sassetti, 2008). These carbon-metabolizing
genes were also found to be up-regulated in microarray analysis
of in vitro MTB-infected host cells (Schnappinger et al, 2003; Data
ref: Schnappinger et al, 2003; Rohde et al, 2007; Data ref: Rohde
et al, 2007), along with a significant overlap of other differentially
expressed genes between the datasets (Appendix Table S2). These
data demonstrate that the Path-seq method yielded data consistent
with published transcriptional studies of in vitro infected host
cells. Importantly, the Path-seq method allows for simultaneous
expression profiling of host and pathogen transcripts and
additional transcript features that are not possible in microarray
studies.
desA1 and desA2 are induced early during in vitro macrophage
infection and hypoxia time course
Among the mycolic acid biosynthesis genes, only umaA was up-
regulated at all time points and desA1/desA2 were transiently up-
regulated at 2 h following MTB infection of BMDMs. Similarly,
umaA, desA1, and desA2 were also found to be up-regulated in the
in vitro infection microarray analyses (Schnappinger et al, 2003;
Data ref: Schnappinger et al, 2003; Rohde et al, 2007; Data ref:
Rohde et al, 2007), but none of the other mycolic acid biosynthesis
genes that were up-regulated in vivo. In the in vitro infection using
Path-seq, after 2 h, desA1/desA2 returned to levels similar to extra-
cellular MTB at 8 h and 24 h (Fig 2A). This expression dynamics of
desA1/desA2 during MTB infection of BMDMs was also mirrored in
RNA-seq data of MTB entering and exiting hypoxia over a 5-day
time course (Fig 2B). In this experiment, we used mass flow con-
trollers to regulate the amount of air and nitrogen (N2) gas stream-
ing into cultures of MTB and achieve a gradual depletion of oxygen
over 2 days. The cultures were maintained in hypoxia for 2 days by
streaming only N2 and then reaerated over 1 day by a controlled
increase in air flow. During the 2-day oxygen depletion, the expres-
sion levels of desA1 and desA2 did not change significantly. How-
ever, as soon as the cultures reached complete hypoxia (0%
dissolved oxygen), the expression of the desaturases increased for
~5 h, followed by a dramatic repression after ~30 h of being in
hypoxia. Subsequently, reaeration of the culture returned desA1 and
desA2 to basal expression levels (Fig 2B). Interestingly, umaA was
not significantly differentially expressed across the hypoxia time
course.
Gene expression comparison between in vivo and in vitro
infections
In addition to the mycolic acid biosynthesis gene, we further com-
pared all significantly differentially expressed genes between the
two infection models and found only a small but significant (P-
value < 0.01) subset of common genes (59 genes at 24 h and 137
genes from any in vitro time point, Dataset EV3 and Appendix Fig
S4). Most of the common genes were up-regulated in both models
and included genes significantly enriched in categories related to the
ribosome and response to hypoxia according to MTB annotation in
DAVID (Huang da et al, 2009a,b). Interestingly, both AAA+
ATPases, clpX (Rv2457c), and clpC1 (Rv3596c) that interact with
the ClpP proteolytic core (Neuwald et al, 1999; Raju et al, 2014)
were also significantly up-regulated in both models. Despite these
few similarly expressed genes, the strikingly different gene expres-
sion profiles between the experimental infection models could
reflect heterogeneity in host cells. Huang et al (2018) recently
demonstrated in mice that MTB has lower bacterial stress in AMs
compared to interstitial macrophages (IMs) at 2 weeks post-infec-
tion. The authors theorize that different host macrophage lineages
represent different intracellular environments that are permissive
(AMs) or restrictive (IMs) for MTB growth (Huang et al, 2018). Our
data also point toward differences in the MTB transcriptional state
from macrophages of different lineages.
Table 1. Genome mapping statistics from Path-seq and RNA-seq from
in vitro infection of MTB-infected BMDMs.
Fraction of MTB reads of all aligned
reads (%)
Path-seq RNA-seq
Intracellular 2 h: a 77.0 0.73
Intracellular 2 h: b 71.1 0.53
Intracellular 2 h: c 88.5 0.65
Intracellular 8 h: a 47.7 0.54
Intracellular 8 h: b 87.5 0.66
Intracellular 8 h: c 82.8 0.38
Intracellular 24 h: a 97.4 3.97
Intracellular 24 h: b 75.5 1.88
Intracellular 24 h: c 97.5 3.10
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Systems-level comparison of active MTB regulatory networks
illustrates differences between infection models
Given the transcriptome differences between the infection models,
we employed a computational framework to characterize, at sys-
tems scale, the transcriptional differences between the extracellular
and intracellular states for each model. There are numerous meth-
ods for identifying the key transcriptional networks from different
environments (Balazsi et al, 2008; Brynildsen & Liao, 2009; Cahan
et al, 2014). Based on one such approach, NetSurgeon (Michael
et al, 2016), we evaluated the role of each TF in the observed gene
expression changes given a signed transcriptional network. We con-
structed a transcriptional network based on ChIP-seq data from
overexpression of 178 of 214 TFs in MTB (Minch et al, 2014; Data
ref: Minch et al, 2015). Activating and repressing influences of TFs
were inferred from consequence of TF overexpression on down-
stream genes (Rustad et al, 2014; Data ref: Rustad et al, 2014).
Using a data-driven transcriptional network of 4,635 interactions,
each TF–target gene interaction was weighted according to the mul-
tiple hypothesis-adjusted P-value from differential expression analy-
sis between intracellular and extracellular conditions. We calculated
a relative score for each TF in conditions simulating deletion or
overexpression of the TF. These simulations prioritized TF activities
(decreased or increased) yielding a transcriptome most similar to
the infected state, compared to the control (see Materials and Meth-
ods and summary schematic in Fig 3A). We performed this analysis
for each time point and infection model to identify highly ranked
TFs (Fig 3B).
From the in vitro macrophage infection, many of the TFs had dis-
tinct temporal activity, while others were highly ranked across all
time points (Fig 3B). These sustained regulons include DosR, which
is known to contain a set of ~50 genes that are induced in response
to multiple signals including hypoxia, nitrosative stress, and carbon
monoxide (Park et al, 2003; Kendall et al, 2004; Roberts et al, 2004;
Kumar et al, 2008). While DosR regulon induction is typically asso-
ciated with hypoxic conditions and reactive nitrogen intermediates
(RNIs), we observed activation as early as 2 h post-infection.
Encouragingly, this 2 h induction was also found in the microarray
study of MTB-infected macrophages, where high DosR regulon
expression was sustained until a striking down-regulation at Day 8
(Rohde et al, 2012). This indicates that the known cues of this regu-
latory network are present almost immediately during in vitro infec-
tion. In addition to DosR, two other TFs had high activity across all
time points, Rv0681 (Fig 3C) and Rv0691c. Interestingly, both are
TetR family transcriptional regulators and conserved across all
mycobacterial genomes (Balhana et al, 2015), including the drasti-
cally reduced Mycobacterium leprae. The function of these transcrip-
tional networks is unknown, but suggests their activity is important
for survival in both environmental and intracellular niches.
Among the TFs with decreased activity, KstR and KstR2 were
found across all time points of the in vitro infection and are known
to repress genes required for cholesterol utilization (Kendall et al,
2010). Our analysis indicates that reduction of their repressive activ-
ity, and increased expression of their target genes, is important for
driving the in vitro intracellular transcriptional state. This is consis-
tent with the highly expressed cholesterol utilization and methyl
citrate cycle genes that we and others have observed (Schnappinger
et al, 2003; Rohde et al, 2007; Homolka et al, 2010). Moreover, this
emphasizes the importance of altered carbon metabolism and uti-
lization of host-derived nutrients as key to MTB in vitro intracellular
adaptation. Another repressor, Zur (previously FurB), had decreased
activity across all time points (Fig 3D). Zur down-regulates genes
involved in zinc transport (Maciag et al, 2007). During MTB infec-
tion, macrophages overload the phagosome with copper and zinc as
a strategy to poison the pathogen (Neyrolles et al, 2015). However,
through multi-faceted resistance mechanisms we do not fully appre-
ciate, MTB is able to protect itself against metal toxicity. Our analy-
sis proposes that reduced Zur activity results in increased
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Figure 2. The expression levels of desA1 and desA2 from Path-seq ofMTB-
infected BMDMs and over a hypoxia time course.
A Path-seq profiles of desA1 and desA2 in MTB-infected BMDMs. Error bars
show the standard deviation from three biological samples. Representative
results from two experiments are presented.
B Upper panel: dissolved oxygen curve over 120-h time course showing
controlled depletion (1), sustained hypoxia (2), and controlled reaeration (3).
Points represent the average of three biological replicates and were
measured via fiber optic technology that non-invasively probes oxygen
levels in the culture (PreSens Precision Sensing GmbH). Lower panel:
expression profiles (RNA-seq) of desA1 and desA2 over the time course and
oxygen levels. Error bars show the standard deviation from three biological
samples.
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expression of zinc transport genes which could help with regulating
zinc levels in MTB during in vitro macrophage infection. Interest-
ingly, other regulators of metal content (TFs, uptake and export)
were recently found to be required for in vitro intracellular growth
by high-content imaging of an MTB transposon mutant library
(Barczak et al, 2017). Leveraging our Path-seq data, we developed a
systems-level approach that recapitulates known in vitro intracellu-
lar regulatory networks and prioritizes others for further experimen-
tal testing.
We also applied the same analysis to the in vivo expression data
(using differentially expressed genes in Dataset EV1) to identify
transcriptional networks involved in MTBs response within AMs.
Interestingly, we observed very few networks that were active in
both infection models. Only Rv0691c was highly ranked at 24 h
from both AMs and BMDMs (Fig 3E). In our regulatory network,
Rv0691c has ~50 target genes, a subset of which are up- and down-
regulated during in vitro and in vivo infection. The genes in the
regulon do not categorize into a certain pathway, but our unbiased
analysis suggests the Rv0691c regulon deserves further study for its
role in establishing MTB infection both in vitro and in vivo. Overall,
there were far fewer active networks identified in vivo, compared to
the in vitro infection. While the type of differentially expressed
genes (i.e., genes not belonging to regulons) could contribute to
such differences, we do not see that being the case. Therefore, it is
appealing to speculate that the more permissive environment within
AMs or a greater heterogeneity of infection from the in vivo model
could contribute to the differences in the number of active regula-
tory networks identified by NetSurgeon.
Identification of EGRIN module relevant to infection and desA1/
desA2 transcriptional regulator, Rv0472c
Our systems analysis revealed novel and infection-specific regula-
tory networks. However, none of the identified regulons included
the mycolic acid biosynthesis genes up-regulated in vivo, and partic-
ularly umaA and desA1/desA2 that were up-regulated in both infec-
tion models. One plausible explanation could be the regulon size
threshold that was implemented to reduce false positives (TFs with
at least five targets were considered in this analysis). Therefore, we
used an orthogonal network approach to discover regulatory mecha-
nisms controlling the expression of these genes that could be impor-
tant for mycolic acid remodeling during infection. Specifically, we
used the environment and gene regulatory influence network
(EGRIN) model of MTB that was previously published and demon-
strated to accurately predict regulatory interactions through valida-
tion with the DNA binding sites and transcriptional targets from
overexpressing > 150 MTB transcription factors (TFs; Peterson et al,
2015; Turkarslan et al, 2015). The full description of the algorithms
used to construct the EGRIN model is beyond the scope of this
work; readers are encouraged to refer to the original paper for more
detail (Reiss et al, 2006). Briefly, the EGRIN model was constructed
through semi-supervised biclustering of a compendium of 2,325
transcriptomes assayed during MTB response to diverse environ-
mental challenges, guided by biologically informative priors and
de novo cis-regulatory GRE detection for module (also referred to as
bicluster) assignment. Overall, the EGRIN model is sufficiently pre-
dictive to formulate hypotheses of MTB regulatory interactions that
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Figure 3. Systems approach to identify active intracellular regulatory networks.
A Schematic of network analysis to identify TFs with activity (increased or decreased) in controlling the transcriptional state of MTB during infection of host cells.
Abbreviations: dec; decreased, inc; increased.
B Heatmap of TFs with decreased (purple) or increased (green) activity at specific time points during in vitro or in vivo infection.
C Rv0681 regulon genes differentially expressed in vitro and the evidence for predicted high Rv0681 activity (induced expression of target genes).
D Zur regulon genes differentially expressed in vitro and the evidence for decreased Zur activity (derepresses target genes).
E Rv0691c regulon genes differentially expressed in vitro and in vivo; evidence for increased Rv0691c activity (increased up- and down-regulation of target genes) at
24 h from both in vitro and in vivo infection.
Data information: (C-E) Boxplots represent log2 fold change (FC) values of TF target genes. The boxes show the median and first/third quartiles of the log2 FC values; the
whiskers extend to the smallest/largest values that are no further than 1.5 times the inter-quartile range.
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respond to various environmental conditions, including new condi-
tions not represented in the gene expression compendium such as
in vivo infection. Using the EGRIN model, we identified significant
enrichment (multiple hypothesis-corrected P-value = 4.9 × 109) of
the in vivo up-regulated mycolic acid biosynthesis genes in bicluster
276 and with predicted regulation by the TF, Rv0472c (Fig 4A).
Bicluster 276 contains the desaturases, desA1/desA2, and PDIM syn-
thases, ppsD/E, all of which were up-regulated in vivo. Furthermore,
bicluster 276 contains the toxin–antitoxin system, vapB/C47, which
was also significantly up-regulated in vivo (with log2 fold change of
3.5 and 3.0, respectively). The PDIM biosynthesis and transport
genes, fad26, drrABC, and papA5, are additional gene members of
module 276. Interestingly, all of the PDIM-related genes of module
276 genes (ppsD/E, drrABC, papA5) were identified in a high-
content imaging analysis of bacterial mutants during macrophage
infection (Barczak et al, 2017). More specifically, they found
mutants of these genes impaired intracellular survival and reduced
type I interferon (IFN) response in host cells (Barczak et al, 2017).
Although the detrimental versus beneficial relevance of type I IFN in
MTB infection remains a matter of active debate, growing evidence
suggests type I IFN promotes bacterial expansion and pathogenesis
within host cells (Moreira-Teixeira et al, 2018). As such, we presume
module 276 genes are up-regulated upon in vivo infection to collec-
tively alter cell wall composition and modulate the immune system,
thereby promoting MTB survival and proliferation within AMs.
The EGRIN model predicted regulation of module 276 by a TetR-
type TF, Rv0472c, with homologs across all mycobacteria, including
M. leprae (Balhana et al, 2015). When overexpressed in MTB,
Rv0472c led to significant repression of 15 genes, but only desA1
and desA2 had significant binding of Rv0472c in their promoter
region from ChIP-seq analysis (Minch et al, 2014; Data ref: Minch
et al, 2015). Given the conservation of Rv0472c across mycobacte-
ria, we hypothesized that overexpression of the MSM homolog
should also repress the desaturases in MSM (Fig 4A). We cloned
MSMEG_0916 into an anhydrotetracycline (ATc)-inducible Gateway
shuttle vector as previously described for MTB (Galagan et al, 2013;
Data ref: Minch et al, 2015) and transformed into MSM. We induced
expression of MSMEG_0916 for 4 h and harvested chromatin sam-
ples for ChIP-seq as well as RNA for transcriptional profiling by
RNA-seq. Overexpression of MSMEG_0916 resulted in nine signifi-
cant ChIP peaks (P-value < 0.01) with a peak score higher than 0.7,
as analyzed by DuffyNGS ChIP peak calling method (see Methods).
Among these were peaks located in the promoter of the MSM desA1
and desA2 (Fig 4B). Additionally, MSMEG_0916 overexpression
resulted in significant repression of desA1 and desA2, with a log2
fold change of 1.32 and 1.72, respectively, compared to unin-
duced (Fig 4C). The DNA consensus motifs, generated using MEME
and DNA binding data from ChIP-seq, also had significant alignment
between Rv0472c and MSMEG_0916 (Appendix Fig S5).
This analysis demonstrates the utility of EGRIN to identify the
regulator of genes relevant to infection. Yet, the Rv0472c and
MSMEG_0916 overexpression data support the direct regulation of
only desA1/desA2, among bicluster 276 genes. It is worth noting
that EGRIN biclusters can be overlapping sets of co-regulated genes
that, in some cases, group together genes from different regulons
and, in other cases, subdivide genes of the same regulon, or even
the same operon. This conditional modularity captures complex
gene regulatory programs for combinatorial control for thousands of
genes by few hundred TFs. While a significant number of bicluster
276 genes are up-regulated during in vivo infection, not all of the
genes are necessarily regulated by the same TF. As such, bicluster
276 represents a coordination of regulatory mechanisms that bring
together functionally related genes. These genes, involved in biosyn-
thesis/transport of PDIM and desaturation of mycolic acids, act
together to alter cell wall composition, thereby affecting cell wall
permeability and host responses during in vivo infection.
Inducible overexpression of MSMEG_0916 or Rv0472c causes loss
of mycobacterial viability and reduction in mycolate biosynthesis
Motivated by our identification of Rv0472c and MSMEG_0916 as
controlling the expression of desA1 and desA2, we hypothesized
that overexpression-mediated repression of the desaturases should
have phenotypes similar to the desA1 knockout that was previously
characterized (Singh et al, 2016). We tested the viability of the TF
overexpression strains by spotting serial 10-fold dilutions of cultures
on agar plates with or without ATc. Plates with MTB and Rv0472c
overexpression strain were incubated for 3 weeks, and growth pat-
terns indicated that the presence of ATc resulted in a 4-log fold
reduction in CFU counts (Fig 5A). In comparison, plates containing
the parental MTB strain showed no change in CFUs with the pres-
ence or absence of ATc (Fig 5A). Similar experiments were done in
Mycobacterium bovis BCG (BCG) and MSM with Rv0472c and
MSMEG_0916 overexpression, respectively. Overexpression resulted
in 3-log viability reduction in BCG (Appendix Fig S6A) and 2-log
viability reduction in MSM (Appendix Fig S6B). We also observed
very limited growth in broth culture when MSMEG_0916 was
induced with ATc (Appendix Fig S7).
Overexpression of the conserved TF resulted in a loss of
mycobacterial viability, due to repression of desA1 and desA2 and
ensuing decrease in mycolic acid biosynthesis. Conditional deple-
tion of DesA1 in MSM leads to an intermediate decrease in desatura-
tion prior to complete loss of mycolic acids (Singh et al, 2016). To
test for a decrease in mycolic acid biosynthesis, we labeled cultures
of MSMEG_0916 overexpression strain with 14C acetic acid following
growth in the presence or absence of ATc. Thin layer chromatogra-
phy (TLC) analysis of apolar lipids demonstrated that overexpres-
sion of MSMEG_0916 reduced the levels of trehalose dimycolates
(TDMs; Appendix Fig S8). We also analyzed methyl esters of
mycolic acids (MAMEs) obtained from apolar lipids using 2D-argen-
tation TLC analysis, designed to separate each subclass of mycolic
acid based on saturation levels. MAME analysis revealed an accu-
mulation of products that migrate identically to our previous obser-
vation with DesA1 depletion (Singh et al, 2016) (Fig 5B) and most
likely correspond to mono-unsaturated mycolates. Similarly, 1D
TLC separation of fatty acid methyl esters (FAMEs) and MAMEs
from apolar lipids confirmed the general decrease in MAMEs and an
accumulation of FAMEs when Rv0472c is overexpressed in BCG
(Fig 5C and densitometric analysis in Appendix Fig S9). This charac-
teristic profile of total MAME inhibition and FAME accumulation
mirrors what is seen with fatty acid synthase (FAS)-II inhibitors,
such as isoniazid (Vilcheze et al, 2000) and thiolactomycin (Kremer
et al, 2000), and confirms the involvement of DesA1 and DesA2 in
the biosynthesis of mycolic acids and more specifically with the
FAS-II system. Interestingly, in BCG there was no accumulation of
mono-unsaturated mycolates as those found in MSM upon detailed
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Figure 4. EGRIN model predicts module 276 relevant to in vivo infection and regulation of desA1 and desA2 by Rv0472c (MSMEG_0916).
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B Plot of read pile-ups from MSM with inducible overexpression of MSMEG_0916 shows ChIP binding in the promoters of desA1 and desA2.
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analysis of MAMEs by 2D-argentation TLC (Appendix Fig S10A and
B). This could be due to key differences in mycolate subclasses
between MSM and MTB, particularly cyclopropane ring formation,
which is abundant in MTB but not MSM and requires a precursory
desaturation event.
Discussion
During MTB infection, the bacterium utilizes various mechanisms to
ensure its own survival and persistence in the host. The intracellular
context is paramount for identifying such mechanisms via
observation and interpretation of gene expression changes. While
hypoxia, low pH, and nutritional stress are used as proxies, they do
not reproduce the spatiotemporal complexity of host-induced stress.
As such, there is no substitute for understanding the authentic intra-
cellular context other than transcriptionally profiling pathogens
directly from infected cells and tissues. The development of Path-
seq has enabled such studies and confirmed mycolic acid biosynthe-
sis as a well-known virulence factor (Barry et al, 1998). Mycolates,
essential for mycobacterial cell wall rigidity, not only make up a
lipid-rich barrier in the mycobacterial cell envelope, they also act as
potent immunomodulators, driving the pathogenesis of MTB, pri-
marily as part of the cord factor (TDM; Marrakchi et al, 2014;
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Figure 5. Cell viability and mycolic acid characterization.
A Serial 10-fold dilutions of MTB H37Rv wild type (wt) and MTB with inducible overexpression of Rv0472c were spotted on 7H10 agar plates with or without ATc.
B Argentation TLC of 14C-labeled methyl esters of mycolic acids (MAMEs) obtained from apolar lipids and delipidated cell wall fractions of MSM wt and MSM with
inducible overexpression of MSMEG_0916. The a, aʹ, epoxy (e), and cyclopropanated a- (X1) MAMEs species are labeled. Faster-migrating species that co-migrated with
a-MAMEs and accumulate with induced MSMEG_0916 overexpression are indicated as X2 and X3.
C BCG wt and BCG with inducible overexpression of Rv0472c cultures, labeled with 14C-acetate, were induced (+ATc) or uninduced (ATc) for 4 h or 8 h. The total
FAMEs and MAMEs were extracted and analyzed by autoradiography–TLC using equal counts (15,000 cpm) for each lane.
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Nataraj et al, 2015). Here, we present evidence that mycolate
biosynthesis is tightly regulated in response to the intracellular envi-
ronment. Using our novel Path-seq method, we observed signifi-
cantly induced expression of mycolic acid biosynthesis genes,
umaA, pcaA, desA1, desA2, fadD32, and fabD, 24 h after MTB
infection of mice. Using multiple systems-level approaches to under-
stand the regulatory control of these virulence genes, we validated
that desA1 and desA2 are regulated by Rv0472c (MSMEG_0916) and
that Rv0472c-mediated repression leads to reduced mycolate biosyn-
thesis and loss of mycobacterial viability. As DesA1 and DesA2 have
been shown to be involved in mycolic acid biosynthesis via desatu-
ration of the merochain, we have therefore named their transcrip-
tional regulatory protein MadR (for mycolic acid desaturase
regulator).
Not much is known about the regulation of mycolic acid biosyn-
thesis apart from two transcription factors shown to regulate distinct
operons, both containing genes encoding core FAS-II proteins
(Salzman et al, 2010; Jamet et al, 2015). Studying the regulatory
alterations to mycolate subclasses remains an even greater chal-
lenge, especially during infection. Our studies show that MadR is
involved in the in vivo and in vitro regulation of desA1 and desA2,
coding for enzymes involved in mycolic acid desaturation (Singh
et al, 2016). The introduction of double bonds in the mycolate
merochain precedes cyclopropanation and other merochain modifi-
cations that are critical for pathogenic mycobacteria (Glickman
et al, 2000; Rao et al, 2005, 2006; Barkan et al, 2012). Loss of
cyclopropanation can lead to hyperinflammatory responses and
attenuated infection. As the introduction of double bonds in the
merochain is required for subsequent cyclopropanation and other
merochain modifications, DesA1 and DesA2 could be drivers of
both mycolic acid biosynthesis and composition during infection.
In other words, MadR-driven regulation not only leads to lower
mycolate levels during dormancy, a state when new cell wall
material is not synthesized, but also altered cyclopropane ring for-
mation by varying desaturation levels, thus affecting virulence and
persistence.
Surprisingly, we observed early (2 h post-infection) induced
expression of desA1 and desA2 during MTB infection of BMDMs,
followed by return to basal levels by 8 h. This is consistent with the
reported increased production of TDM within the first 30 min after
in vitro phagocytosis (Fischer et al, 2001) and suggests that the
desaturases play a role in cell wall modifications that occur in
response to intracellular cues. However, the presence of these intra-
cellular cues appears to be different in AMs from infected mice. The
overall disparity in the transcriptional profile of MTB from BMDMs
and AMs is both intriguing and disturbing. The active MTB net-
works we identified from BMDMs imply the presence of early and
sustained bacterial stress. However, the induction of these stress-
related networks is absent in the transcriptomes of MTB from AMs,
suggesting the bacteria are not experiencing the same type or
amount of stimuli in AMs. These data support recent observations
using fluorescent MTB reporter strains, demonstrating that bacilli in
AMs exhibit lower stress and higher bacterial replication than those
in interstitial macrophages (Huang et al, 2018). Similarly, we
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Figure 6. Model of MadR regulation of mycolic acid desaturases.
Under normal growth conditions, MadR exists in equilibrium between the free and DNA-bound forms, and a basal level of desA1 and desA2 expression is maintained. DesA1
and DesA2 act with other enzymes of the fatty acid synthase-II (FAS-II) complex to produce mycolic acids for new cell wall. Infection of macrophages and early stress cues
shifts the equilibrium toward the free form of MadR, and the repression of desA1 and desA2 is released. The desaturase protein levels increase, introducing double bonds that
allow cyclopropanation and other modifications to alter the cell wall. These changes enable the bacteria to withstand intracellular stresses and establish infection. As
infection continues and stress is sustained, MadR binds tightly to the promoter of desA1 and desA2, leading to stringent repression of the desaturases. MadR-mediated
repression of desA1 and desA2 leads to irregular fatty acids of medium length and the pausing of mycolic acid biosynthesis to enter into dormancy. The DNA-bound form of
MadR is shown in complex with a yet unknown co-factor that leads to repression of the desaturases.
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hypothesize that MTB responds divergently to macrophages of dif-
ferent lineages and that AMs present fewer stresses and possibly a
more permissive environment compared to BMDMs. It is also worth
mentioning that the data raise some concerns with respect to the
use of BMDMs as an appropriate infection model.
Our data lead us to propose a model for MadR regulation of
desA1 and desA2 transcription as summarized in Fig 6. Under nor-
mal growth conditions, MadR exists in equilibrium between the free
and DNA-bound forms, thus maintaining basal levels of desA1 and
desA2 transcripts. Upon macrophage infection and early hypoxia,
equilibrium favors unbound MadR which derepresses desA1 and
desA2 transcription and increases mRNA levels. As infection pro-
gresses and reaches later stages of hypoxia, MadR has increased
binding affinity in the promoters of desA1 and desA2 and represses
their transcription to below basal levels. Ultimately, the MadR regu-
latory system enables mycobacteria to efficiently alter mycolate
biosynthesis and composition in response to environmental signals.
We suspect the early response to infection (desA1 and desA2
up-regulation) increases desaturation events and allows MTB to
fine-tune cyclopropanation and other merochain modifications that
contribute to the establishment of infection. However, mycolate
biosynthesis is energetically expensive and MadR-mediated repres-
sion occurs in later stages of infection. The reduction in mycolate
biosynthesis allows MTB to enter dormancy and facilitates long-
term persistence.
The question remains how MadR is able to differentially bind to
DNA in response to environmental changes. In mycobacteria, other
TFs regulating mycolate biosynthesis are modulated by long-chain
acyl-CoAs (Biswas et al, 2013; Mondino et al, 2013; Tsai et al,
2017), proposing a role for these molecules in the modulation of
MadR as well. Similarly, a MadR homolog in Pseudomonas aerugi-
nosa, DesT, was shown to have enhanced DNA binding in the pres-
ence of unsaturated acyl-CoAs (Zhang et al, 2007). These studies
support the notion that a select acyl-CoA ligand may control MadR
DNA binding affinity (as shown in Fig 6) and thus the expression of
desA1 and desA2.
The characterization of the MadR regulon provides valuable
insight for understanding the evolution of MTB. While we have
shown the regulation by MadR is conserved from MSM to MTB,
our results also suggest the fatty acid desaturation events and
resulting mycolate subclasses and surface lipids have evolved,
specializing for bacterial survival in the host environment. These
findings propose mycobacterial evolution from saprophyte to
pathogen has occurred through the adaptation of ancestral genes
and regulatory networks to function in the host environment. Ulti-
mately, this study demonstrates the in vivo significance of the
desaturases and their regulation by MadR. We believe the Path-seq
method, described and employed here, offers a sensitive and tract-
able approach to elucidate the molecular mechanisms used by
MTB during host infection, potentially at the single-cell level. Our
detailed characterization of one such mechanism has revealed that
modulation of MadR activity can affect cell wall composition as
well as mycobacterial viability. Accordingly, we have established
Path-seq as a powerful tool for uncovering the minimally studied
in vivo biology of this pathogen and revealed the essentiality of
MadR encoded program for cell wall remodeling and biosynthesis.
As such, we present MadR as a new and important antitubercular
target.
Materials and Methods
Reagents and Tools table
Reagent/Resource Reference or Source Identifier or Catalog Number
Experimental Models
H37Rv (M. tuberculosis) D. Sherman lab N/A
mc2155 (M. smegmatis) A. Bhatt lab N/A
BCG Pasteur (M. bovis) A. Bhatt lab N/A
C57BL/6J (M. musculus) Jackson Lab B6.129P2Gpr37tm1Dgen/J
Recombinant DNA
pDTCF-Msmeg0916 (M. smegmatis) This study N/A
pDTCF-Rv0472c (M. tuberculosis) D. Sherman lab, Minch et al (Data ref: Minch et al, 2015) N/A
pMV306-eGFP-Zeo L. Kremer lab, Bernut et al (2016) N/A
Antibodies
M2 anti-FLAG Sigma F1804
Rat anti-mouse CD16/32 (clone 2.4G2) BD Pharmingen 553142
Mouse anti-Siglec F (clone E50-2440) BD Pharmingen 552125
Mouse anti-CD11b (clone M1/70) BioLegend 101201
Mouse anti-CD64 (clone X54-5/7.1) BioLegend 139321
Mouse anti-CD45.2 (clone 104) BioLegend 109815
Mouse anti-CD3 (clone 17A2) eBioscience 14-0032-81
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Reagents and Tools table (continued)
Reagent/Resource Reference or Source Identifier or Catalog Number
Mouse anti-CD19 (clone 1D3) eBioscience 11-0193-81
Oligonucleotides and sequence-based reagents
Cloning primers This study see Methods and Protocols
Chemicals, enzymes and other reagents
Zombie Violet dye BioLegend 423113
TRIzol Invitrogen 15596026
RPMI Medium (1640) Gibco 11875093
Anhydrotetracyline Sigma-Aldrich 37919
Hygromycin B Invitrogen 10687010
Protease inhibitor cocktail Sigma-Aldrich P2714
Middlebrook OADC enrichment BD Difco 212351
Middlebrook ADC enrichment BD Difco 212352
Middlebrook 7H10 agar BD Difco 262710
Middlebrook 7H9 broth BD Difco 271310
Petroleum Ether 60–80°C Fisher Chemicals P/1480/17
Chloroform, 99.8+% Fisher Chemicals C/4960/17
Methanol, AR Fisher Chemicals M/4000/17
Sodium chloride Fisher Chemicals S/3160/65
Tetrabutylammonium hydroxide solution 40 wt.
% in H2O
Sigma-Aldrich 178780
Dichloromethane, 99+% Fisher Chemicals D/1850/17
Iodomethane (stabilised with silver) for synthesis Merck 806064
Diethyl ether, AR Fisher Chemicals D/2450/17
TLC Silicagel 60 F₂₅₄ Merck 1055540001
Acetone, AR Fisher Chemicals A/0600/17
Silver nitrate, Ultrapure Grade, 99.5% Acros Organics 419361000
Acetic Acid, Sodium Salt, [1-14C]-, 1mCi (37MBq) PerkinElmer NEC084H001MC
Kodak® BioMax® MR film Sigma-Aldrich Z353949-50EA
Software
DuffyNGS Vignali et al (2011) http://networks.systemsbiology.net/mtb/
NetSurgeon Michael et al (2016) http://mblab.wustl.edu/software.html
DESeq2 Love et al (2014) https://github.com/mikelove/DESeq2
Adobe Photoshop CC 2015 https://www.adobe.com
Other
Direct-zol RNA MicroPrep kit Zymol Research R2060
Dynabeads M-270 Streptavidin Invitrogen 65306
Lysing Matrix B tubes MP Biomedicals MP116911050
SureSelectXT strand-specific RNA kit Agilent 5190-6410
SureSelectXT target enrichment kit Agilent 5190-4393
Probe library M_tub_h37rv_ASM19595v2_32_1 Agilent This study, ELID number 3037441
TruSeq stranded mRNA library prep kit Illumina RS-122-2103
Ribo-Zero magentic kit bacteria Illumina MRZB12424
Ribo-Zero magentic kit epidemiology Illumina MRZE724
NextSeq 500/550 High output kit Illumina FC-404-2002
SMARTer ThruPLEX DNA-seq kit Takara R400523
Illumina NextSeq 500 Illumina
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Methods and Protocols
Culturing conditions
Mycobacteria strains were cultured in Middlebrook 7H9 with the
ADC supplement (Difco), 0.05% Tween-80 at 37°C under aerobic
conditions with constant agitation. Strains containing the anhy-
drotetracycline (ATc)-inducible expression vector were grown
with the addition of 50 lg/ml hygromycin B to maintain the
plasmid. Growth was monitored by OD600 and colony-forming
units (CFUs). For experiments featuring madR overexpression
strains, overexpression was induced for the approximate duration
of one cell doubling (18 h for MTB and BCG, 4 h for MSM)
using an ATc concentration of 100 ng/ml culture. Wild-type and
overexpression strain cultures were grown into mid-log phase.
For assessing growth on agar plates, broth cultures were
adjusted to OD600 of 0.5, and serial dilutions were spotted on
7H10 containing 0.5% (v/v) glycerol and 10% (v/v) OADC
plates, with or without 100 ng/ml ATc. In the case of the over-
expression strain, 50 ng/ml hygromycin was added to the solid
medium. For growth in broth, MSM mid-logarithmic phase cul-
tures containing the integrative vector pMV306-eGFP-Zeo (Bernut
et al, 2016) were inoculated in an initial OD600 0.05 in 200 ll
of 7H9 supplement with 0.2% (v/v) glycerol, 0.05% (v/v)
Tween-80, and 10% (v/v) OADC with or without 100 ng/ml
ATc in sealed 96-well Costar 3603 black-sided clear-bottomed
plate incubated at 37°C. Fluorescence was acquired every 30 min
for 30 h at 37°C, in a PHERAstar FS microtiter plate reader
(BMG Labtech), using 485 nm and 520 nm as excitation and
emission wavelengths, respectively. When growing BCG or MSM
for lipid extraction, cultures were cultured up to OD600 0.5.
Then, they were induced with 100 ng/ml ATc (Sigma-Aldrich)
final concentration and labeled with acetic acid [1–14C] 1 mCi/
ml (PerkinElmer), if hot lipid analysis was going to be per-
formed. MSM samples were collected the following day, while
BCG cultures at 4 and 8 hours post-induction.
Strains
To investigate the growth properties of MadR overexpression, we
used strains containing an ATc- inducible expression vector of the
gene, as described previously (Galagan et al, 2013; Jaini et al,
2014; Rustad et al, 2014; Data ref: Minch et al, 2015). The pDTCF-
Rv0472c (kind gift of David Sherman) was transformed into M. bo-
vis BCG and M. tuberculosis H37Rv for viability and mycolic acid
characterization. Mycobacterium tuberculosis H37Rv (kind gift of
David Sherman) was also used for Path-seq experiments. For
MadR overexpression in M. smegmatis (MSMEG_0916), we created
entry clones through PCR amplification of the gene template from
mc2155 gDNA, adding the necessary Gateway recombination
sequences to the PCR product, as described in Minch et al (Data
ref: Minch et al, 2015). The primers used for the Gateway entry
cloning pDONR221 vector are 50-GGGGACAAGTTTGTACAAAA
AAGCAGGCTCTGTGGCACAGCAGACTCCACCG-30 (forward) and
50-GGGGACCACTTTGTACAAGAAAGCTGGGTCGTCAAGCAGGTGC
CGCGGCGG-30 (reverse). We inserted the gene into the same
E. coli-mycobacterial episomal shuttle vector (pDTCF) modified
as described in Minch et al (Data ref: Minch et al 2015). The
pDTCF-MSMEG0916 plasmid was transformed into M. smegmatis
mc2155.
Mice
C57BL/6 mice were purchased from the Jackson Laboratory. All
mice were housed and bred under specific pathogen-free conditions
at Seattle Children’s Research Institute (SCRI). All experimental pro-
tocols involving animals were approved by the Institutional Animal
Care and Use Committee of (SCRI).
Aerosol infection
A mid-log-phase stock of MTB H37Rv was used to infect mice in
an aerosol infection chamber (Glas-Col). Bacterial load in the
lungs was determined by plating serial dilutions from homogenized
lungs.
Cell isolation, analysis, and sorting
1 Bronchoalveolar lavage was performed by first exposing the tra-
chea of euthanized mice.
2 The exposed trachea was punctured using Vannas Micro Scissors
(VWR), and 1 ml PBS was injected using a 20G-1” IV catheter
(McKesson) connected to a 1-ml syringe.
3 The PBS was flushed into the lung and aspirated three times, and
the recovered fluid was placed in a 15-ml tube on ice.
4 The 1 ml PBS wash was then repeated three additional times for
a total of 4 ml recovered fluid.
5 Cells were filtered, spun down, and resuspended in a 96-well
plate for antibody staining.
6 Cells were suspended in 1X PBS (pH 7.4) containing 0.01% NaN3
and 1% fetal bovine serum (i.e., FACS buffer).
Fc receptors were blocked with anti-CD16/32 (2.4G2, BD
Pharmingen). Cell viability was assessed using Zombie Violet dye
(BioLegend). Surface staining included antibodies specific for
murine Siglec F (E50-2440, BD Pharmingen), CD11b (M1/70, BioLe-
gend), CD64 (X54-5/7.1, BioLegend), CD45 (104, BioLegend), CD3
(17A2, eBiosciences), and CD19 (1D3, eBiosciences). Cell sorting
was performed on a FACSAria (BD Biosciences). Cells were col-
lected in complete media, spun down, resuspended in TRIzol, and
frozen at 80° overnight prior to RNA isolation.
BMDM infection
BMDMs were isolated from C57BL/6J mice and cultured in RPMI
(RPMI containing 10% (v/v) FBS and 2 mM L-glutamine) with
recombinant human CSF-1 (50 ng/ml) for 6 days and then
replated. BMDMs were infected on Day 7 with MTB H37Rv strain
(MOI 10), followed by washing 3× with RPMI at 2 h post-infection,
and fresh media was added. BMDMs were lysed with TRIzol
(Invitrogen), and total RNA was isolated from mixed host–
pathogen sample. The same MTB H37Rv cultures used for BMDM
infection were also diluted to starting OD600 = 0.1 and grown in
7H9.
Hypoxia time course
An Oxygen Sensor Spot (PreSens, Regensburg, Germany) was
adhered within a 1-l disposable spinner flask with two side arms
(Corning, Corning, NY). A velcro belt with a screw-on port for
the fiber optic cable was wrapped around the flask. A gas line
input was fastened on one arm of the flask, and a Luer-Lock/
filter sampling port was connected to the other arm. Air and N2
gas lines were run into the Biological Safety Laboratory and con-
nected to gas-specific mass flow controllers (Alicat, Tucson, AZ),
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whose outputs were connected downstream through a Y-
connector that led into an incubator. Three separate flasks, all
prepared as described above, were placed onto a stir plate inside
an incubator at 37°C. The mixed gas line was split via addi-
tional Y-connectors, streamed through 0.2-lm filters, and
attached to the gas line inputs of each flask. Media was incu-
bated overnight and checked for contamination before inoculated
with MTB.
The mass flow controllers and oxygen sensor were linked to a
computer and remotely controlled and monitored in real time. After
inoculation of 700 ml 7H9 media with MTB H37Rv at starting
OD600 of 0.01, we programmed the mass flow controllers to achieve
a changing gas mixture gradient, which allowed us creating a steady
2-day depletion, followed by 2 days of sustained hypoxia, and reaer-
ation by flowing pure air into the headspace of the vessels and
increasing the speed of the stir bars in each vessel. Samples were
collected by attaching a Luer-Lock syringe to the sampling port.
Samples were centrifuged at high speed for 5 min, supernatant was
discarded, and cell pellet was immediately flash frozen in liquid
nitrogen.
RNA isolation
Cell pellets in TRIzol were transferred to a tube containing Lysing
Matrix B (MP Biomedicals) and vigorously shaken at max speed for
30 s in a FastPrep 120 Homogenizer (QBiogene) three times. This
mixture was centrifuged at max speed for 1 min, and the super-
natant was transferred to a fresh tube. RNA from extracellular MTB
samples, BMDM infection, hypoxia time course, and madR overex-
pression was isolated using the Direct-zol RNA MicroPrep Kit
(Zymol Research) according to manufacturer’s instruction with on-
column DNase treatment.
RNA from mice infection was isolated by the following method:
• 200 ll chloroform was added to 1 ml of TRIzol.
• Samples were inverted and incubated for 2–3 min, and the upper
aqueous phase was collected.
• A second chloroform extraction was done, followed by addition of
1 ll glycogen and 500 ll isopropanol.
• Samples were incubated with isopropanol for 10 m at room tem-
perature and centrifuged, and supernatant was discarded.
• Pellet was washed with 1 ml 70% ethanol twice.
• All ethanol was removed, the pellet dried (15 m), and resus-
pended in 12 ll RNase-free water.
For all RNA samples, total RNA yield was quantified by
NanoDrop (Thermo Scientific) and quality was analyzed in a
2100 Bioanalyzer system (Agilent Technologies). Following
DNase treatment, total RNA samples were depleted of ribosomal
RNA using the Ribo-Zero Gold rRNA Removal Kit “epidemiol-
ogy” (Illumina).
Probe design
Non-overlapping head-to-tail 120-nucleotide probes were designed
using the Array software (Agilent Technologies). A total of 35,624
probes were designed to cover 3,924 M. tuberculosis H37Rv ORFs
(Agilent probe library M_tub_h37rv_ASM19595v2_32_1, ELID num-
ber 3037441). Using Megablast, it was verified that all genes of MTB
were matched by at least one probe and that only a negligible frac-
tion of the probes could be mapped on the mouse and human cDNA
sequences from Ensembl.
Preparation of libraries for transcriptional sequencing
RNA libraries for Path-seq were prepared using the SureSelectXT
strand-specific RNA target enrichment for Illumina multiplexed
sequencing. RNA libraries for RNA-seq were prepared using the
SureSelectXT strand-specific RNA kit, but were not hybridized to
probes and indexed separately.
Briefly, the protocol followed was as follows:
• RNA from rRNA-depleted samples was enzymatically fragmented,
and double-stranded cDNA was produced with adapters ligated to
both ends.
• The library was then amplified using provided primers which
hybridize to the previously inserted adapters, therefore allowing a
linear amplification to all transcripts present in the sample. In the
case of non-enriched RNA-seq samples, sample indexes were also
inserted during this PCR.
• For Path-seq libraries, double-stranded cDNA ligated to adapters
was also amplified and then incubated at 65°C for 24 h with the
set of biotinylated oligonucleotides specifically designed to cap-
ture MTB transcripts, as described above.
• The hybridized sequences were captured with magnetic strepta-
vidin beads (M-270, Invitrogen).
• They were next linearly amplified using provided primers and
indexed during PCR.
Before sequencing, libraries were assessed for quality and frag-
ment size by Bioanalyzer and with a Qubit Fluorometer (Invitrogen)
to determine cDNA concentration. Resulting libraries were
sequenced on the Illumina NextSeq Instrument using mid output
150 v2 reagents. Paired-end 75 bp reads were processed following
Illumina default quality filtering steps.
Transcription abundance from sequencing data
Raw FASTQ read data were processed using the R package
DuffyNGS as described previously (Vignali et al, 2011). Briefly, raw
reads pass through a 3-stage alignment pipeline: (i) a prealignment
stage to filter out unwanted transcripts, such as rRNA, mitochon-
drial RNA, albumin, and globin; (ii) a main genomic alignment
stage against the genome(s) of interest; and (iii) a splice junction
alignment stage against an index of standard and alternative exon
splice junctions. Reads from samples of mixed host–pathogen RNA
and extracellular MTB controls were aligned to a combined M. tu-
berculosis H37Rv (ASM19595v2) and Mus Musculus (GRCm38.p6)
genome. Reads from samples of MSM RNA were aligned to
M. smegmatis mc2155 genome (ASM1500v1). All alignments were
performed with Bowtie 2 (Langmead & Salzberg, 2012), using the
command line option “very-sensitive”. BAM files from stages 2 and
3 are combined into read depth wiggle tracks that record both
uniquely mapped and multiply mapped reads to each of the forward
and reverse strands of the genome(s) at single-nucleotide resolution.
Multiply mapped reads are prorated over all highest-quality aligned
locations. Gene transcript abundance is then measured by summing
total reads landing inside annotated gene boundaries, expressed as
both RPKM and raw read counts. Two stringencies of gene abun-
dance are provided using all aligned reads and by just counting
uniquely aligned reads.
Differential expression
For both infection models (in vitro and in vivo), we used DESeq2
(Love et al, 2014) to identify gene expression changes between
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intracellular and extracellular MTB at each sampled time point. We
used rounded raw read counts estimated by DuffyNGS (as described
above) as input for DESeq2. Genes with absolute log2 fold change
bigger than one and multiple hypothesis-adjusted P-value below
0.01 and 0.05, for the in vitro and in vivo data, respectively, were
considered differentially expressed. For the in vivo samples, only
genes with non-zero counts in any of the replicates were considered
in DESeq2.
For Msmeg0916 overexpression, we used a panel of 5 DE tools to
identify gene expression changes between induced (+ATc) and unin-
duced (ATc). The tools included (i) RoundRobin (in-house); (ii)
RankProduct (Breitling et al, 2004); (iii) significance analysis of
microarrays (SAM) (Tusher et al, 2001); (iv) EdgeR (Robinson &
Smyth, 2008); and (v) DESeq2 (Love et al, 2014). Each DE tool was
called with appropriate default parameters and operated on the
same set of transcription results, using RPKM abundance units for
RoundRobin, RankProduct, and SAM and raw read count abun-
dance units for DESeq2 and EdgeR. All 5 DE results were then syn-
thesized, by combining gene DE rank positions across all 5 DE tools.
Specifically, a gene’s rank position in all 5 results was averaged,
using a generalized mean to the 1/2 power, to yield the gene’s final
net rank position. Each DE tool’s explicit measurements of differen-
tial expression (fold change) and significance (P-value) were simi-
larly combined via appropriate averaging (arithmetic and geometric
mean, respectively). Genes with averaged absolute log2 fold change
bigger than one and multiple hypothesis-adjusted P-value below
0.01 were considered differentially expressed.
MTB signed transcriptional network
We compiled a signed (stating the positive or negative nature of
each TF–gene interaction) wiring diagram of MTB transcriptional
regulatory network. The compiled MTB network included 4,635 TF–
gene interactions (2,296 and 2,339 instances of activation and
repression, respectively) with both physical (detected with ChIP-seq
experiments) and functional evidence (detected with transcriptional
profiling). The compiled network contained 2,001 genes and 136
TFs with at least one target. The initial ChIP-seq derived MTB net-
work consisted of 6,581 interactions occurring in the 150 bp to
+70 bp region of genes’ promoter reported by Minch et al (Data ref:
Minch et al 2015). We expanded that MTB ChIP-seq network by tak-
ing into account operon organizations. For a given TF–gene interac-
tion, if the target gene is part of an operon, we included all other
members of the operon as potential targets of the corresponding TF.
The expanded MTB ChIP-seq network contained 12,188 interac-
tions. Finally, we filtered out interactions that did not change at
least 20% in the relevant TF-overexpressing strain (compared to the
WT strain). Up-regulation of the target gene in the TF-overexpres-
sing strain was interpreted as positive interaction (the opposite for
down-regulation).
Identification of transcription factors with differential activity in
intracellular MTB (using NetSurgeon)
We identified potential TFs with increased or decreased regulatory
activity in intracellular MTB (respect to extracellular controls) at
each sampled time point using the method recently developed by
Michael et al (2016) called the NetSurgeon algorithm. Briefly,
NetSurgeon identifies TFs whose differential regulatory activity is
likely responsible for the observed transcriptional changes between
two states of interest. In our case, we wanted to identify TFs that
drive differential expression between intracellular MTB and their
controls. Changes in TF activities are estimated based on the expres-
sion of their target genes (derived from DESeq2 output). TF regulons
are extracted from a signed transcriptional regulatory network speci-
fied by the user. The signed MTB transcriptional network model
used in this study is described above (and available at: http://net
works.systemsbiology.net/mtb). NetSurgeon’s scoring is based on
the hypergeometric test distribution (Michael et al, 2016). Three
important NetSurgeon’s considerations are as follows: (i) Increase
and decrease in TF activity are independently scored; (ii) only target
genes differentially expressed (according to user’s defined P-values,
q-values, and fold change cutoffs) in the proper direction impact TF
scores. This means that in case of increased activity, only genes sig-
nificantly down-regulated and up-regulated will contribute to the
score of their repressors and activators, respectively; and (iii) TF
scores are defined not only by the number of target genes that are
differentially expressed in the correct direction, but also by their
adjusted P-values (associated with the differential expression analy-
sis performed with DESeq2). The weight of each gene in the scores
of its transcriptional regulators is proportional to the –log2 of its
adjusted P-value. Thus, NetSurgeon’s score is not homogeneous dis-
tributed among TFs’ targets but it is affected by the differential
expression significance of each gene. To reduce false positives (i.e.,
misleading presence of TFs with small number of known targets at
the top of our TF scores ranking) due to overlap between regulons,
only TFs with at least five targets were considered in this analysis.
Furthermore, we considered TFs in the top 15 of NetSurgeon’s score
ranking as the ones with differential activity. This threshold was
selected based on the NetSurgeon’s results when we compared sus-
ceptible and antibiotic resistance Escherichia coli transcriptomes.
Among the top 15 TFs, we were able to recall TFs known to be
involved in multidrug resistance (such as MarA and homolog Rob,
Ruiz & Levy, 2010). TFs with < 5 targets with differential expression
or with contradicting trends (similar number of activated and
repressed targets moving in the same direction) were excluded from
the NetSurgeon’s top 15 ranking. For the in vivo and 8 h in vitro
data, the next two TFs outside the top 15 ranking were included to
compensate for multiple TFs that were filtered out.
ChIP-seq
The madR overexpression strain was induced for the approximate
duration of one cell doubling (4 h for MSM) using an ATc concen-
tration of 100 ng/ml culture. DNA–protein interactions were charac-
terized as described previously (Data ref: Minch et al, 2015).
Libraries were prepared using ThruPLEX DNA-seq Kit (Takara)
using standard protocol. Samples were sequenced on the Illumina
550 NextSeq instrument, generating unpaired 20–30 million 75-bp
reads per sample. Raw FASTQ read data were processed using the R
package DuffyNGS as described previously (Vignali et al, 2011). For
consensus motif determination, we searched for conserved DNA
sequences within  50 nucleotides of high-quality (score > 0.7)
ChIP-seq peak centers using MEME (Bailey & Elkan, 1994).
Measuring viability of madR overexpression strains
Wild-type and madR overexpression strain cultures were grown into
mid-log phase. For assessing growth on agar plates, OD of the broth
culture was adjusted up to 0.5, and serial dilutions were spotted in
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7H10 containing 0.5% (v/v) glycerol and 10% (v/v) OADC plates,
with or without 100 ng/ml ATc. In the case of the overexpression
strain, 50 ng/ml hygromycin was added to the solid medium.
Extraction and analysis of total lipids and mycolic acids
Lipids were extracted from BCG and MSM cells in three fractions as
describes by Dobson et al (1985), with a few modifications. Briefly,
outside apolar lipids from dried pellets were extracted with two con-
secutive extractions with 4 ml of petroleum ether (60–80°C) and
dried. Then, inside apolar and polar lipids were extracted following
Dobson protocol.
Outside, inside apolar, and polar lipid extracts, along with delipi-
dated pellets from MSM and BCG, were subjected to alkaline hydrol-
ysis using tetrabutylammonium hydroxide (TBAH) as previously
described (Kremer et al, 2002). Aliquots (15,000 cpm) from each
outside, inside apolar, and polar lipid extracts were analyzed by thin
layer chromatography (TLC) utilizing Silica Gel 60 F254 plates
(Merck) developed once in the solvent system CHCl3/CH3OH/H2O
(60:16:2, v/v/v). However, FAME and MAME aliquots (15,000 cpm)
were resolved through TLC using petroleum ether/acetone (95:5,
v/v) or by two-dimensional silver ion argentation thin layer chro-
matography (2D-TLC; Kremer et al, 2002). Autoradiograms were
produced after exposing Carestream Kodak BioMax MR film for
3 days. To determine the intensity of TLC spots, densitometric analy-
sis using Adobe Photoshop CC 2015 was performed.
Data availability
The datasets and computer code produced in this study are available
in the following databases:
• In vivo Path-seq data: Gene Expression Omnibus GSE116394
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116394
• In vitro Path-seq/RNA-seq data: Gene Expression Omnibus
GSE116357 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE116357
• MadR RNA-seq data: Gene Expression Omnibus GSE116027
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116027
• MadR ChIP-seq data: Gene Expression Omnibus GSE116084
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116084
• Hypoxia/reaeration RNA-seq data: Gene Expression Omnibus
GSE116353 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE116353
• The Gene Regulatory Network to implement NetSurgeon: MTB
Network Portal Data Center http://networks.systemsbiology.net/
mtb/data-center
• R notebook with scripts for performing computation analyses:
GitHub https://github.com/baliga-lab
Expanded View for this article is available online.
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